Background: The COVID-19 pandemic has impacted the conduct of clinic visits. We conducted a study to evaluate two academic laboratories' fingerstick capillary blood collection kits suitable for home use for laboratory measurement of HbA1c. Methods: Four clinical sites recruited 240 participants (aged 4-80 years, HbA1c 5.1%-13.5%). Capillary blood samples were obtained by the participant or parent using collection kits from two laboratories (University of Minnesota Advanced Research and Diagnostic Laboratory (ARDL) and Children's Mercy Hospital Laboratory (CMH)) and mailed under varying shipping conditions by United States Postal Service to the laboratories. Comparisons were made between HbA1c measurements from capillary samples and contemporaneously obtained venous samples. The primary outcome was percentage of capillary HbA1c values within 5% of the corresponding venous values. Results: HbA1c values were within 5% of venous values for 96% of ARDL kit specimens shipped with a cold pack and 98% without a cold pack and 99% and 99%, respectively, for the CMH kits. R2 values were 0.98, 0.99, 0.99, and 0.99, respectively. Results appeared similar across HbA1c levels and for pediatric and adult participants. Usability survey scores were high. Conclusions: Capillary blood collection kits, suitable for home use, from two academic laboratories, were demonstrated to be easy to use and provided results that are comparable with those obtained from venous specimens. Based on these results, there is strong evidence that HbA1c measurements from capillary specimens obtained with these specific kits can be used interchangeably with HbA1c measurements from venous specimens for clinical research and clinical care.
Background: The COVID-19 pandemic has impacted the conduct of clinic visits. We conducted a study to evaluate two academic laboratories' fingerstick capillary blood collection kits suitable for home use for laboratory measurement of HbA1c. Methods: Four clinical sites recruited 240 participants (aged 4-80 years, HbA1c 5.1%-13.5%). Capillary blood samples were obtained by the participant or parent using collection kits from two laboratories (University of Minnesota Advanced Research and Diagnostic Laboratory (ARDL) and Children's Mercy Hospital Laboratory (CMH)) and mailed under varying shipping conditions by United States Postal Service to the laboratories. Comparisons were made between HbA1c measurements from capillary samples and contemporaneously obtained venous samples. The primary outcome was percentage of capillary HbA1c values within 5% of the corresponding venous values. Results: HbA1c values were within 5% of venous values for 96% of ARDL kit specimens shipped with a cold pack and 98% without a cold pack and 99% and 99%, respectively, for the CMH kits. R2 values were 0.98, 0.99, 0.99, and 0.99, respectively. Results appeared similar across HbA1c levels and for pediatric and adult participants. Usability survey scores were high. Conclusions: Capillary blood collection kits, suitable for home use, from two academic laboratories, were demonstrated to be easy to use and provided results that are comparable with those obtained from venous specimens. Based on these results, there is strong evidence that HbA1c measurements from capillary specimens obtained with these specific kits can be used interchangeably with HbA1c measurements from venous specimens for clinical research and clinical care.
Entities:
Keywords:
Accuracy; HbA1c measurement; Home A1c testing; Type 1 diabetes; Type 2 diabetes; adults; children
Authors: Jane Lynch; Lauren G Kanapka; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney Balliro; Peter Calhoun; Roy W Beck Journal: Diabetes Technol Ther Date: 2022-10 Impact factor: 7.337
Authors: Roy W Beck; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney Balliro; Zoey Li; Peter Calhoun Journal: Diabetes Technol Ther Date: 2022-10 Impact factor: 7.337
Authors: Laurel H Messer; Bruce A Buckingham; Fran Cogen; Mark Daniels; Greg Forlenza; Rabab Z Jafri; Nelly Mauras; Andrew Muir; R Paul Wadwa; Perrin C White; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney A Balliro; Zoey Li; Martin Chase Marak; Peter Calhoun; Roy W Beck Journal: Diabetes Technol Ther Date: 2022-10 Impact factor: 7.337
Authors: David M Nathan; Heidi Krause-Steinrauf; Barbara H Braffett; Valerie L Arends; Naji Younes; Paula McGee; Claire Lund; Mary Johnson; Gayle Lorenzi; Xiaoyu Gao; Michael W Steffes; John M Lachin Journal: PLoS One Date: 2021-11-15 Impact factor: 3.240
Authors: Thomas Martens; Roy W Beck; Ryan Bailey; Katrina J Ruedy; Peter Calhoun; Anne L Peters; Rodica Pop-Busui; Athena Philis-Tsimikas; Shichun Bao; Guillermo Umpierrez; Georgia Davis; Davida Kruger; Anuj Bhargava; Laura Young; Janet B McGill; Grazia Aleppo; Quang T Nguyen; Ian Orozco; William Biggs; K Jean Lucas; William H Polonsky; John B Buse; David Price; Richard M Bergenstal Journal: JAMA Date: 2021-06-08 Impact factor: 56.272
Authors: Grazia Aleppo; Roy W Beck; Ryan Bailey; Katrina J Ruedy; Peter Calhoun; Anne L Peters; Rodica Pop-Busui; Athena Philis-Tsimikas; Shichun Bao; Guillermo Umpierrez; Georgia Davis; Davida Kruger; Anuj Bhargava; Laura Young; John B Buse; Janet B McGill; Thomas Martens; Quang T Nguyen; Ian Orozco; William Biggs; K Jean Lucas; William H Polonsky; David Price; Richard M Bergenstal Journal: Diabetes Care Date: 2021-09-29 Impact factor: 19.112